GLA
NERV icon

Good Life Advisors’s Minerva Neurosciences NERV Stock Holding History

Good Life Advisors’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,250
Closed -$8K – 382
2022
Q1 		$8K Hold
1,250
– – ﹤0.01% 387
2021
Q4 		$8K Hold
1,250
– – ﹤0.01% 391
2021
Q3 		$17K Hold
1,250
– – ﹤0.01% 369
2021
Q2 		$23K Hold
1,250
– – ﹤0.01% 316
2021
Q1 		$29K Hold
1,250
– – 0.01% 315
2020
Q4 		$23K Hold
1,250
– – 0.01% 273
2020
Q3 		$32K Hold
1,250
– – 0.01% 247
2020
Q2 		$36K Buy
+1,250
New +$73.3K 0.01% 247

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Good Life Advisors's NERV Position: Q2 2022 in Review

Good Life Advisors sold out of Minerva Neurosciences (NERV) in Q2 2022, closing a stake of 1,250 shares — an estimated $8K sold.

Good Life Advisors first reported a position in NERV in Q2 2020 and held it in 8 quarters. The position peaked at $36K in Q2 2020. 23 funds tracked by Wall St. Rank hold NERV as of Q2 2022.

  • Good Life Advisors reported no remaining Minerva Neurosciences position as of Q2 2022 after selling out during the quarter.
  • Good Life Advisors sold 1,250 Minerva Neurosciences shares in Q2 2022, an estimated $8K.
  • Good Life Advisors first reported a position in Minerva Neurosciences in Q2 2020 and held it in 8 quarters.
  • Good Life Advisors's Minerva Neurosciences position peaked at $36K in Q2 2020.
  • 23 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2022.

Based on Good Life Advisors's 13F filing for Q2 2022, filed 19 Jul 2022.